Medtronic CoreValve Evolut R U.S. Clinical Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 241 participants.
Also called NCT02207569
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 241 participants
- Sponsor
- Registry
-
NCT02207569
-
- Other papers using this trial's data
- Early Clinical Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Who Are Suboptimal for Surgery: Results of the Evolut R U.S. Study
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02207569. Allocation not applicable; no masking; primary purpose treatment. Start 2014-08 (registry gives no type); primary completion 2015-08 (actual). Results posted on 2017-12-12.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Medtronic CoreValve Evolut R U.S. Clinical Study
- Condition
- Aortic Stenosis
- Intervention (Device)
- CoreValve Evolut R TAVR system
- Lead sponsor
- Medtronic Cardiovascular
Record details
- Record id
cardio:ct-nct02207569- Content hash
114fa4deb39f5de71b30f8448605eaaed522956c49893edb46055e6f4fb077be